Vaccine Aesi Characterization Study Presentation

Media Summary: Project lead George Hripcsak (Columbia University) shared this Hana Amer provides a video commentary on a JBI best practice implementation project entitled, 'Coronavirus disease 2019 ... Join Dr. Bailey, Dr. Messonnier and Dr. Cohn for a comprehensive overview of the CDC's role in

Vaccine Aesi Characterization Study Presentation - Detailed Analysis & Overview

Project lead George Hripcsak (Columbia University) shared this Hana Amer provides a video commentary on a JBI best practice implementation project entitled, 'Coronavirus disease 2019 ... Join Dr. Bailey, Dr. Messonnier and Dr. Cohn for a comprehensive overview of the CDC's role in

Photo Gallery

Vaccine AESI Characterization Study Presentation (George Hripcsak, 2/23/21 OHDSI Community Call)

OHDSI Study: Calculating background rates of adverse events of special interest for COVID vaccines

Select Your Masterclass 3 - Vaccine Characterization and Analytics

Post-marketing Vaccine Adverse Events Identification and Individual Differences Analysis

Long COVID Phenotyping and Vaccine Effectiveness Methods (Kristin Kostka/Annika Jodicke, Nov. 16)

October 2017 ACIP Meeting - Adult Immunization ; Child/Adolescent Immunization ; JE vaccine

Understanding the Vaccine Adverse Event Reporting System

Sept 22, 2021 ACIP Meeting - Vaccine effectiveness studies & impact of booster doses

Advisory Committee on Immunization Practices (ACIP) - December 4, 2025 - Day 1 of 2

Adverse Events of Special Interest within COVID-19 Subjects (Erica Voss • Nov. 16)

COVID-19 vaccine adverse events: Best practice reporting

FDA analysis finds Pfizer-BioNTech coronavirus vaccine meets "success criteria"

View Detailed Profile

Vaccine AESI Characterization Study Presentation (George Hripcsak, 2/23/21 OHDSI Community Call)

Vaccine AESI Characterization Study Presentation (George Hripcsak, 2/23/21 OHDSI Community Call)

Project lead George Hripcsak (Columbia University) shared this

OHDSI Study: Calculating background rates of adverse events of special interest for COVID vaccines

OHDSI Study: Calculating background rates of adverse events of special interest for COVID vaccines

Study

Select Your Masterclass 3 - Vaccine Characterization and Analytics

Select Your Masterclass 3 - Vaccine Characterization and Analytics

Featuring: Indresh Srivastava (Novavax)

Post-marketing Vaccine Adverse Events Identification and Individual Differences Analysis

Post-marketing Vaccine Adverse Events Identification and Individual Differences Analysis

Post-marketing

Long COVID Phenotyping and Vaccine Effectiveness Methods (Kristin Kostka/Annika Jodicke, Nov. 16)

Long COVID Phenotyping and Vaccine Effectiveness Methods (Kristin Kostka/Annika Jodicke, Nov. 16)

Annika Jodicke and Kristin Kostka

October 2017 ACIP Meeting - Adult Immunization ; Child/Adolescent Immunization ; JE vaccine

October 2017 ACIP Meeting - Adult Immunization ; Child/Adolescent Immunization ; JE vaccine

Proposed changes in the 2018 adult

Understanding the Vaccine Adverse Event Reporting System

Understanding the Vaccine Adverse Event Reporting System

Learn more about the

Sept 22, 2021 ACIP Meeting - Vaccine effectiveness studies & impact of booster doses

Sept 22, 2021 ACIP Meeting - Vaccine effectiveness studies & impact of booster doses

Vaccine

Advisory Committee on Immunization Practices (ACIP) - December 4, 2025 - Day 1 of 2

Advisory Committee on Immunization Practices (ACIP) - December 4, 2025 - Day 1 of 2

The Advisory Committee on

Adverse Events of Special Interest within COVID-19 Subjects (Erica Voss • Nov. 16)

Adverse Events of Special Interest within COVID-19 Subjects (Erica Voss • Nov. 16)

Erica Voss

COVID-19 vaccine adverse events: Best practice reporting

COVID-19 vaccine adverse events: Best practice reporting

Hana Amer provides a video commentary on a JBI best practice implementation project entitled, 'Coronavirus disease 2019 ...

FDA analysis finds Pfizer-BioNTech coronavirus vaccine meets "success criteria"

FDA analysis finds Pfizer-BioNTech coronavirus vaccine meets "success criteria"

The U.K. began its nationwide

AMA Webinar: CDC Review Process for COVID-19 Vaccine Candidates (Episode 2 of a series)

AMA Webinar: CDC Review Process for COVID-19 Vaccine Candidates (Episode 2 of a series)

Join Dr. Bailey, Dr. Messonnier and Dr. Cohn for a comprehensive overview of the CDC's role in